BNR · Burning Rock Biotech Ltd ADR
United States · RS rating 35 · As of 2026-11-03
| Price | 10.94 USD |
|---|---|
| 1-day change | +9.0% |
| RS rating (overall / 1M / 3M / 12M) | 35 / 11 / 91 / 37 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 26 / 17 / 24 |
| Industry group (rank) | Medical-Services (63) |
| EPS growth Q/Q | +6.2% |
| Sales growth Q/Q | -4.0% |
| Distance from 52-week high | +73.4% |
| Market cap (USD) | $221.7M |